Alagille Syndrome

Rare disease drug development funding increased 28% in 2021

According to a new report by the rare disease organization Global Genes, interest in the rare disease space is growing, with a total of $22.9 billion raised by rare disease therapeutic developers in 2021. In 2020, $18 billion was raised. “Rare diseases continue to have a strong allure to investors,...